WGS GeneDx Holdings Corp.
$45.46
GeneDx Holdings Corp. (WGS) Earnings News
Earnings press releases, previews and reviews for GeneDx Holdings Corp. (WGS), newest first. Our most recent is review: GeneDx Crushes EPS Consensus on Margin Gains, but Lower Volume Guidance Exposes a Business Trading Growth for Profitability.
Monday
November 9, 2026
6:54 PM ET
GeneDx Crushes EPS Consensus on Margin Gains, but Lower Volume Guidance Exposes a Business Trading Growth for Profitability
Earnings Whispers · Review
Monday
November 9, 2026
4:05 PM ET
GeneDx Reports Third Quarter 2026 Financial Results
Monday
November 2, 2026
9:01 PM ET
GeneDx Must Show Carelon Coverage Gains Are Reaching Its Collection Rates
Earnings Whispers · Preview
Friday
October 23, 2026
4:05 PM ET
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Friday
October 2, 2026
8:30 AM ET
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
Tuesday
August 11, 2026
8:30 AM ET
GeneDx Launches New Online Offering for Families to Improve Accessibility of Exome Testing for Children with Global Developmental Delay, Intellectual Disability and Epilepsy
Monday
August 3, 2026
4:05 PM ET
GeneDx Reports Second Quarter 2026 Financial Results
Thursday
July 16, 2026
4:05 PM ET
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
Thursday
June 4, 2026
3:30 PM ET
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS
Thursday
May 28, 2026
9:00 AM ET
GeneDx Holdings (WGS) 49% Drop Triggers Investor Scrutiny Over Disconnect From Prior Growth Narrative- HBSS